NEWS ARCHIVE

2018

10/3/2018

Boston Pharmaceuticals Acquires Three Novel Anti-Infective Programs from Novartis

10/3/2018

Boston Pharmaceuticals Adds Five New Drug Programs to Its Pipeline in Licensing Deal

2/6/2018

Boston Pharmaceuticals to Present at 2018 BIO CEO & Investor Conference

1/4/2018

Pierre Fabre Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Selective Potassium Channel Blocker for Atrial Fibrillation

2017

8/28/2017

Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitor for Solid Tumors

2015

11/19/2015

Former Sanofi chief to launch Boston Phamaceuticals with $600m

11/19/2015

Viehbacher’s $2B biotech fund wagers $600M on an R&D upstart

11/19/2015

Ex-Sanofi CEO drug hunting with $600M